SML0230

GW-803430

≥98% (HPLC)

• Synonym(e): 6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-3H-thieno[3,2-d]pyrimidin-4-one, GW-3430, GW-803430A
• Empirische Formel (Hill-System): C₂₅H₂₄ClN₃O₃S
• CAS-Nummer: 515141-51-2
• Molekulargewicht: 481.99
• UNSPSC-Code: 51111800
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: white to beige
• Löslichkeit: DMSO: ≥4 mg/mL at warmed to 60 °C
• Ersteller: GlaxoSmithKline
• Lagertemp.: 2-8°C
• SMILES String: [s]1c2c(nc[n]([c]2=O)c4cc(c(cc4)OCCN5CCCC5)OC)cc1c3ccc(cc3)Cl
• InChI: 1S/C25H24ClN3O3S/c1-31-22-14-19(8-9-21(22)32-13-12-28-10-2-3-11-28)29-16-27-20-15-23(33-24(20)25(29)30)17-4-6-18(26)7-5-17/h4-9,14-16H,2-3,10-13H2,1H3
• InChIKey: MWULMTACIBZPGN-UHFFFAOYSA-N

Beschreibung

Anwendung

GW-803430 may be used in MCHR1-mediated cell signaling studies.

Biochem./physiol. Wirkung

GW-803430 antagonizes central MCHR1 and produces anxiolytic, anti-depressant and anti-obesity effects in rats and mice. It also controls the alcohol-seeking behavior in rats and is a promising treatment for alcohol use-related disorders.

GW-803430 is a centraly active and selective melanin-concentrating hormone receptor (MCHR) 1 antagonist

Leistungsmerkmale und Vorteile

This compound is featured on the Melanin-Concentrating Hormone Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H302,H319
• P-Sätze: P264 - P270 - P280 - P301 + P312 - P305 + P351 + P338 - P337 + P313
• Gefahreneinstufungen: Acute Tox. 4 Oral - Eye Irrit. 2
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable